Free Book Online
Book Glioblastoma Treatment with 2, 5-Dimethyl-Celecoxib (DMC) In Vitro

Pdf

Glioblastoma Treatment with 2, 5-Dimethyl-Celecoxib (DMC) In Vitro

3.4 (3205)

Log in to rate this item

    Available in PDF - DJVU Format | Glioblastoma Treatment with 2, 5-Dimethyl-Celecoxib (DMC) In Vitro.pdf | Language: ENGLISH
    Nathaniel Soriano (Author)

    Book details


2,5-dimethyl-celecoxib (DMC) is a close structural analog of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib (Celebrex®:) that lacks COX-2 inhibitory function yet maintains all of celecoxibs anti-tumor properties. We set out to investigate the potential of combining current glioblastoma chemotherapies with DMC as a new approach to enhance glioblastoma cell killing. DMC was not only able to enhance tumor cell killing when combined with other drugs but also induced glioblastoma growth arrest and apoptosis in low glucose and hypoxic conditions which are normally associated with chemoresistance. Therefore, if DMC were used in combination it may potentially be able to reverse this chemoresistance and restore or even enhance these drugs inhibitory effects. In addition, we also discovered inconsistencies between the MTT assay and other in vitro cell growth and survival assays. Hence, the MTT assay should be used with caution, and its results should be supported by other available in vitro assays.
3.2 (9560)
  • Pdf

*An electronic version of a printed book that can be read on a computer or handheld device designed specifically for this purpose.

Formats for this Ebook

PDF
Required Software Any PDF Reader, Apple Preview
Supported Devices Windows PC/PocketPC, Mac OS, Linux OS, Apple iPhone/iPod Touch.
# of Devices Unlimited
Flowing Text / Pages Pages
Printable? Yes

Book details

  • PDF | 48 pages
  • Nathaniel Soriano (Author)
  • VDM Verlag Dr. Mueller e.K. (16 May 2008)
  • English
  • 2
  • Science Nature

Read online or download a free book: Glioblastoma Treatment with 2, 5-Dimethyl-Celecoxib (DMC) In Vitro

 

Review Text


Name:
Email*:
The message text*: